232 related articles for article (PubMed ID: 189435)
1. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
[TBL] [Abstract][Full Text] [Related]
2. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
Eltringham JR; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
[No Abstract] [Full Text] [Related]
3. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
Libánský J; Lukásová M; Pinosová I
Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
[No Abstract] [Full Text] [Related]
4. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
Churchill WH; Rocklin RR; Moloney WC; David JR
Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
[No Abstract] [Full Text] [Related]
5. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
[TBL] [Abstract][Full Text] [Related]
6. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
[No Abstract] [Full Text] [Related]
7. Degrees of impairment of cell-mediated immune reactivity in Hodgkin's disease.
Petrov M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):201-10. PubMed ID: 61913
[No Abstract] [Full Text] [Related]
8. Delayed skin hypersensitivity reaction in normal children.
Kerr AA; Denton RG
N Z Med J; 1978 Jul; 88(616):57-9. PubMed ID: 360117
[TBL] [Abstract][Full Text] [Related]
9. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of immunocompetence in Hodgkin's disease.
Faguet GB
J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
[TBL] [Abstract][Full Text] [Related]
11. Immunodeficiency in Hodgkin disease.
Eltringham JR; Kaplan HS
Birth Defects Orig Artic Ser; 1975; 11(1):278-88. PubMed ID: 1148383
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
Gaines JD; Gilmer MA; Remington JS
Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
[No Abstract] [Full Text] [Related]
13. Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis.
Elliott ST; Hanifin JM
Arch Dermatol; 1979 Jan; 115(1):36-9. PubMed ID: 367287
[TBL] [Abstract][Full Text] [Related]
14. In vitro leukocyte interferon production in patients with Hodgkin's disease.
Rassiga-Pidot AL; McIntyre OR
Cancer Res; 1974 Nov; 34(11):2995-3002. PubMed ID: 4421578
[No Abstract] [Full Text] [Related]
15. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
[No Abstract] [Full Text] [Related]
16. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
Levo Y; Rotter V; Ramot B
Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
[TBL] [Abstract][Full Text] [Related]
17. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
[No Abstract] [Full Text] [Related]
18. Delayed hypersensitivity in Graves' disease.
Robinson RG; Guttler RB; Rea TH; Nicoloff JT
J Clin Endocrinol Metab; 1974 Feb; 38(2):322-4. PubMed ID: 4591168
[No Abstract] [Full Text] [Related]
19. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
20. Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components.
Tannenbaum H; Rocklin RE; Schur PH; Sheffer AL
Clin Exp Immunol; 1976 Dec; 26(3):511-9. PubMed ID: 795577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]